Toutes les études
RecrutementOBSERVATIONNEL

Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia

This study focuses on people with a condition called Hereditary Haemorrhagic Telangiectasia, often shortened to HHT. It's a condition that can cause problems with blood vessels. Researchers at Hammersmith Hospital in London are reviewing existing health records of patients they have treated over many years. This isn't a new treatment or experiment; it's about looking back at information already collected during regular patient care. They want to see if they can find patterns. For example, they're trying to figure out if certain characteristics of people with HHT mean they are more likely to have complications like strokes, brain infections, issues during pregnancy, or high blood pressure in the lungs. This review helps them learn more about HHT and potentially improve care in the future.

En un coup d'œil

Statut
Recrutement
Sponsor
Imperial College London
Objectif d'inscription
2,000
Démarrer
01 Jan 2000
Achèvement estimé
01 Jan 2028

De quoi parle cette étude ?

This study is about a health condition called Hereditary Haemorrhagic Telangiectasia, or HHT for short. It's a condition that affects blood vessels throughout the body.

The team at Hammersmith Hospital in London has a special clinic for people with HHT and a related problem called pulmonary arteriovenous malformations (which are unusual connections between blood vessels in the lungs). They've been gathering information about their patients as part of their routine care since 1985. This study isn't about giving you new medicines or treatments; instead, it's about looking back at all that existing information.

The main goal is to understand if certain types of people with HHT are more likely to develop specific health problems. For example, they want to see if some patients are more at risk of having strokes, brain infections, complications during pregnancy, or high blood pressure in the lungs. By looking through these past records, researchers hope to identify clues that could help them predict who might be more susceptible to these issues. This knowledge can then be used to potentially offer better and more personalised care to people with HHT in the future.

Points clés

  • This study reviews existing medical records, not new treatments.
  • It aims to understand HHT complications better.
  • Data comes from HHT patients treated at Hammersmith Hospital.
  • No active participation is required from patients.
  • The goal is to improve future HHT patient care.

Qui peut être éligible ?

This study is reviewing information from people who have already been treated at Hammersmith Hospital in London. It includes individuals with Hereditary Haemorrhagic Telangiectasia (HHT).

If you have HHT and have received care at Hammersmith Hospital, your records might be included in this review.

There are no specific reasons why someone would be excluded from having their records included, as long as they were a patient at Hammersmith Hospital with HHT.

Cet étude pourrait-elle vous convenir ?

Répondez à ces questions rapides pour voir si vous êtes éligible. Ceci est un guide uniquement — l'équipe de recherche prend la décision finale.

  1. Have you been diagnosed with Hereditary Haemorrhagic Telangiectasia (HHT)?
  2. Have you received care for your HHT at Hammersmith Hospital in London?
  3. Were your medical records created as part of your standard care at the hospital?
  4. Do you understand that this study is looking at past information, not new treatments?
Répondez à chaque question pour voir votre résultat.

En quoi consiste la participation ?

You won't need to do anything new for this study, as it involves reviewing information that has already been collected during your past visits and care at Hammersmith Hospital. You won't have any extra appointments, tests, or medication as part of this research. Your doctor will simply be looking at your existing medical notes.

Risques et avantages potentiels

There are no direct risks to you from this study, as no new tests or treatments are involved. The study is simply looking at your existing medical historical information. The potential benefit is that by understanding more about HHT, doctors may be able to better predict and manage complications for future patients. You have the right to ask if your records are part of this study and, if so, to discuss any concerns with your healthcare team.

Emplacements (1)

  • Respiratory Medicine, Hammersmith Hospital
    Code postal vérifié
    Londres, Royaume-Uni· Recrutement

Questions fréquentes

What is Hereditary Haemorrhagic Telangiectasia (HHT)?

HHT is a genetic condition that affects blood vessels, which can cause them to be fragile and bleed easily, or to form in unusual ways.

Do I need to do anything if I'm included in this study?

No, you don't need to do anything. This study is reviewing existing patient records, not asking you to take part in new activities.

Mes informations personnelles seront-elles gardées privées ?

Yes, all studies involving patient information are required to protect your privacy and use anonymous data where possible.

Who is conducting this study?

The study is being conducted by researchers at Hammersmith Hospital in London.

Pourquoi cette recherche est-elle importante ?

It's important because it helps doctors learn more about HHT and its complications, which could lead to better care for patients in the future.

Comment en savoir plus

Claire L Shovlin

Parlez toujours à votre médecin généraliste ou spécialiste avant de décider de participer à une étude.

Intéressé à participer ?

Inscrivez votre intérêt

Partagez vos coordonnées et l'équipe de recherche pour "Case Notes Review on Patients With Hereditary Haemorrhagic T… vous contactera si vous êtes éligible. Consultez toujours votre médecin avant d'accepter de participer.

Discussion

Discussion communautaire

Propulsé par notre forum à community.patient.info. Veuillez être respectueux — ceci n'est pas un avis médical.